Dimension Inx
Active, new domainDimension Inx is a regenerative therapeutics company. We design and develop therapeutic products that restore tissue and organ function.
What it does
Dimension Inx is a pioneering regenerative therapeutics company specializing in designing and developing therapeutic products that restore tissue and organ function. Utilizing a materials-centric approach, Dimension Inx creates biofunctional biomaterials that enable unique clinical solutions. By collaborating with biotech and medical device partners, the company addresses challenging materials issues and develops medical products for various therapeutic applications with high unmet clinical needs. Dimension Inx's innovative solutions have the potential to revolutionize the field of regenerative medicine by offering advanced therapeutic options that were previously unattainable. Through their commitment to restoring tissue and organ function, Dimension Inx is at the forefront of driving innovation in the health and medtech industries.
How it has moved
- new domain
The site moved to dimension.bio, same company.
Next to it in Healthcare and bio · regenerative therapeutics biomaterials
- AsantebioPlug and Play
Asante Bio is a joint preservation company that develops revolutionary medical products for early intervention orthopaedic care.
- 株式会社セルージョンPlug and Play
Cellusion is a developer of corneal endothelial regenerative medicine intended to improve world visibility.
- 株式会社ヘリオスPlug and Play
Healios develops treatments for retinal diseases and age-related macular degeneration (AMD) using cell technology.
- 株式会社マトリクソームPlug and Play
Matricome develops regenerative medicines by disseminating laminin E8 fragment technology.
- OralomePlug and Play
Advanced precision medicine developer.
- Rege NephroPlug and Play
Rege Nephro is a biotech company that specialized in R&D, production and marketing of renal disease therapeutics.
- ShasqiY Combinator W15
Targeting Cancer with Click Chemistry
- Cell Reserves IncSOSV SOSV IndieBio RebelBio 03
Developing novel protein and peptide-based therapeutics for the treatment of diseases